Calif. Consumers Want 2nd Shot At Lipitor Antitrust Subclass
Two California women asked a New Jersey court Tuesday to reconsider its ruling that they can't create a subclass of Golden State consumers in antitrust litigation against Pfizer Inc. and Ranbaxy...To view the full article, register now.
Already a subscriber? Click here to view full article